New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
15:56 EDTEPZMEpizyme rises 5.3% to $35.93
A late day move higher in shares of Epizyme came in concert with the posting of a presentation dated August 12, entitled "EZH2 Inhibitor EPZ-6438 (E7438) in Non-Hodgkin Lymphoma: Pre-Clinical Models and Early Clinical Observations," to the company's website. Reference Link
News For EPZM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
07:41 EDTEPZMEpizyme management to meet with Leerink
Subscribe for More Information
June 22, 2015
13:20 EDTEPZMOn The Fly: Top stock stories at midday
Subscribe for More Information
June 21, 2015
15:09 EDTEPZMEpizyme to hold a conference call
Subscribe for More Information
12:37 EDTEPZMEpizyme reports phase 1 tazemetostat results, plans phase 2 trial in Q2
Subscribe for More Information
June 17, 2015
07:17 EDTEPZMOncology Institute of Southern Switzerland to hold a conference
13th International Conference on Malignant Lymphoma: ICML 2015 is being held in Rome, Italy on June 17-20.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use